FLNA
Filana Therapeutics, Inc.
1.29
2 x 1.23
1 x 1.24
bid
ask
+
0.04
3.20%
10:15 AM
timesize
| Ytd | -34.85% | |
| 1y | -35.82% |
1.24
day range
1.32
1.15
52 week range
4.98
| Open | 1.24 | Prev Close | 1.25 | Low | 1.24 | High | 1.32 | Mkt Cap | 62.39M |
| Vol | 88.80K | Avg Vol | 379.98K | EPS | -1.61 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.35 | 200-d Avg | 2.26 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 11.17M | ||
| Research and Development Expense | 4.54M | ||
| Selling, General and Administrative Expense | 6.62M | ||
| Operating Income | -11.17M | ||
| Net Income | -10.33M | ||
| Net Income Common Stock | -10.33M | ||
| Net Income Common Stock (USD) | -10.33M | ||
| Consolidated Income | -10.33M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -10.33M | ||
| Earning Before Interest & Taxes (USD) | -10.33M | ||
| Weighted Average Shares | 48.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 86.57M | ||
| Cash and Equivalents (USD) | 86.57M | ||
| Current Assets | 87.96M | ||
| Property, Plant & Equipment Net | 20.40M | ||
| Total Assets | 108.37M | ||
| Current Liabilities | 40.12M | ||
| Total Liabilities | 40.23M | ||
| Accumulated Retained Earnings (Deficit) | -506.41M | ||
| Shareholders Equity | 68.14M | ||
| Shareholders Equity (USD) | 68.14M | ||
| Assets Non-Current | 20.40M | ||
| Liabilities Non-Current | 111.00K | ||
| Trade and Non-Trade Payables | 39.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 243.00K | ||
| Net Cash Flow from Financing | -51.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.93M | ||
| Net Cash Flow from Operations | -8.88M | ||
| Share Based Compensation | 4.07M | ||